Form 4: BioLife Solutions CFO Troy Wichterman Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Troy Wichterman, CFO of BioLife Solutions, sold 956 shares of common stock on April 18, 2024, to satisfy tax withholding obligations related to vesting restricted stock.
Summary
- On April 18, 2024, Troy Wichterman, the Chief Financial Officer of BioLife Solutions Inc., sold 956 shares of the company's common stock.
- The sale was executed at a price of $15.31 per share.
- This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023.
- The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock.
- Following the transaction, Wichterman directly owns 126,658 shares of BioLife Solutions Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is related to tax obligations and was pre-planned under a Rule 10b5-1 trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine transaction for covering tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although the context of tax obligations mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Date of adoption of Rule 10b5-1(c) trading plan |
| 04/18/2024 | Date of stock sale transaction |
| 04/22/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.